DETAILED DESCRIPTION OF THE INVENTION. In accordance with the present invention, a method for recovering and separating metals from waste streams, comprises the following steps: pH of a waste stream is adjusted;
DETAILED DESCRIPTION OF THE INVENTION. FIG. 1 illustrates a side elevation view of the subsurface drilling tool, particularly a drill bit, of the present invention. A rolling cutter, such as the one herein described, is a cutting element having at least one surface that may rotate within a cutter pocket as the cutting element contacts the drilling formation. As the cutting element contacts the formation, shearing may allow a portion of the cutting element to rotate around a cutting element axis extending through a central plane of the cutting element. The drill bit of the present invention includes a bit body or shank (1 0), wherein the shank (10) comprises a pin end (12) and an opposite cutting end (14). The shank (10) may be formed of material including, for example, metal, carbides, such as tungsten carbide, tantalum carbide, or titanium carbide, nitrides, ceramics and diamond, such as polycrystalline diamond, or a combination thereof. Also illustrated in FIG. 1, the pin end (12) has the usual threaded portion by which it may be connected to a typical drill stem (not shown), although other means standard in the industry such as pins, screws, or other means for attaching a drill bit to a drill stem may be utilized. The construction of the shank (10) may be of a conventional type well known and heretofore extensively used in rolling cutters in a conventional cross roller cutter bit. The cutting end (14) comprises a plurality of ear portions (16), preferably two, located opposite one another on both sides of the shank (10). Moreover, the ear portions (16) extend beyond the shank (10) to assist in forming the cutting end (14) of the shank (10). For instance, the ear portions (16) are configured to form the shape of a socket (18), wherein a ball shaped cutting tool (20) fits inside the socket (18) and is rotatably attached to the plurality of ear portions (16) via an axle (24). Comprising the ball shaped cutting tool (20) is a plurality of cones (22), preferably two, shaped like half-domes and located adjacent to one another to form the ball shape as illustrated in FIG. 1. The ball shaped cutting tool (20) is thus snugly engaged and held in place by the socket (I8). The drill bit of the present invention further includes a locking pin (38) to lock the axle (24) in place, thus, effectively locking the plurality of cones (22) into a set.position. As further illustrated in FIGS. I and 2, when the drill bit is rotated by the drill stem (not shown) in a bore hole, the plurality of cones (22) rotate on...
DETAILED DESCRIPTION OF THE INVENTION. [0040] The present invention is forceps for performing monopolar or bipolar surgery for cutting and/or sealing tissue, e.g., blood vessels, skin, etc. The forceps are shown generally at 1 in Figures 1-1 and 6-1. The forceps 1 generally include a moving handle 2, a stationary handle 3, a tube 5 extending from the stationary handle 3, a tip 7 extending from the tube 5, a pair of jaws 8, 9 extending from the tip 7, a connecting block 23 extending from the moving handle 2, and a hollow shaft 13 movably connecting the moving handle 2 to the jaws 8, 9 via the connecting block 23. [0041] The moving handle 2 includes a clevis top 21 for receiving and retaining the connecting block 23. Referring to Figure 5-1, the clevis top 21 is has a generally block-shaped and defines a block tube cavity 53 and a block pin cavity 50. The connecting block 23 includes a block portion 49 and a block tube 55 extending from the block portion 49. The block portion 49 and a portion of the block tube 55 are inserted within the block tube cavity 53. The block tube 55 includes a pair of block pins 22 which are inserted within the block pin cavity 50 of the clevis top 21 for preventing the connecting block 23 from rotating with respect to the stationary handle 3. [0042] The carrying tube 5 extends from the fixed handle 3 and is covered with an insulating sheath 6, i.e., a dielectric coating. Referring to Figure 3-2, the tip 7 is generally tube shaped and includes a large tube 57 and a small tube 58. The tip 7 defines a duct 60 extending therethrough. The small tube 58 is retained within the carrying tube 5. The large tube 57 is formed into two fingers 59, which encircle the duct 60, for receiving a portion of the jaws 8, 9. The jaws 8, 9 are connected to the tip 7 via a pin 10 which allows the jaws 8, 9 to pivot relative to the tip 7. The jaws 8, 9 are generally rectangular in shape. However, they may be formed into any desired shape. Each jaw 8, 9 defines a slot 16 extending entirely therethrough. A pair of links 11 are connected to the jaws 8, 9 via pins 30. The inner hollow shaft 13 slides within the carrying tube 5 and is connected to the links 11 via a pin 12. The hollow shaft 13 includes first cylinder 62 and a second cylinder 63, of a smaller diameter, extending from the first cylinder 62. The first cylinder 62 is an elongated tube which extends through the stationary handle 3 and is connected to the connecting block 23. The first cylinder 62 of the hollow shaft 13 is connected to t...
DETAILED DESCRIPTION OF THE INVENTION. [00012] This invention relates in one embodiment to systems for imporving the safety in medication use. In another embodiment, the invention relates to the use of matching drug name voice templates as a threshold mechanism for unlocking a medication container. [00013] In one embodiment, provided herein is a system for providing patient-specific drugs, comprising: a drug container, wherein the drug container comprises a locking means; a patient identifying barcode; a drug name identifier; and a computer interface; and a computer, wherein the drug container is connected to the computer and the locking means opens in response to a signal from the computer. [00014] Placement and use of the patient identifying bar-code as described hereinabove, is provided in United States Patent Number 7,347,841 incorporated herein by reference in its entirety. [00015] Reference is now made to figure 1, showing the system 100, comprising a lockable drug container 200, wherein the drug to be prescribed 300 is located. The drug container 200 is locked with a locking means 400, capable of opening the container upon receiving a signal from a computer 600 located in the vicinity of the container 200. Drug 300 identifying means such as a patient identifying bar-code 502 in one embodiment, is displayed on container 200 and is capable of being scanned by an appropraiet reader to verify the patient receiving the drug 300 is the correct patient. Drug name identifier 501 is affixed in the container or on the container and is in communication with a processing unit 500 and a computer interface 501. The computer interface may be a hard wire connected via USB cable or any other appropriate communication means between the container 200 and the computer 600. This may be a wireless communication device as well. Upon receiving a signal from the computer 600, the lock 400 on container 200 may open and allow drug 300 to be administered to a patient in need thereof. In one embodiment, drug container 200 is a pill box, a syringe, infusion bag and valve, a vial, an ampule or a combination thereof. [00016] In another embodiment, provided herein is a system for providing patient-specific drugs, comprising: a drug container 200, wherein the drug container comprises a locking means 400; a patient identifying barcode 502; a drug name identifier 500, wherein the drug name identifier 500 comprises: a computer readable medium containing a stored word template or templates identifying the drug 300 trade name...
DETAILED DESCRIPTION OF THE INVENTION. Detailed embodiments of the present invention are disclosed herein, however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed embodiment. According to the invention, a dental whitening composition having teeth whitening properties is disclosed. In a first illustrative embodiment, the dental whitening composition is formed from a first gel and a second gel. The first gel, according to the invention, is a peroxide gel having about 1 to about 15 percent peroxide by weight. The peroxide gel composition, according to the invention, is formed by mixing approximately 3 gm of a gelling powder, Micropore Gel® powder, Bioserve, San Diego, California, with approximately 97 gm of deionized water. The gelling powder is mixed with the deionized water for approximately one-half hour until a clear flowable gel is formed. The flowable gel is then mixed with approximately 10.98 gm of a 50 percent hydrogen peroxide solution and stirred slowly for approximately 15 minutes. In this first illustrative embodiment Peralkali®, a 50% peroxide solution, Degussa Manufacturing, was used. It is contemplated that other peroxides known in the art may be used such as carbamide peroxide, potassium peroxide, calcium peroxide, or the like. A citric acid buffer is added until the mixture achieves a pH of approximately 3.5. Approximately 2 gm of a dry flavoring is added to the buffered gel composition. The formed buffered peroxide gel will stabilized to about a pH of 5 after about 24 hours. 14 The second gel, is an accelerating gel formed by mixing approximately 3 gm of Micropore® Gel powder with approximately 97 gm of deionized water. This mixture is stirred for approximately one-half hour until a clear flowable gel is formed. The flowable gel is mixed with approximately 3.2 gm of silver ion solution (500ppm). Approximately 10.40 gm of Tri (hydroxymethyl)-aminomethane, Angus Chemical Company, Buffalo Grove, Illinois, is added to approximately 1 gm of water forming a buffering solution. The buffering solution is added to the ionized gel solution forming the accelerating gel. The accelerating gel is contained within an opaque container u...
